Media Centre
Latest press releases
-
AstraZeneca concluye acuerdo para el suministro de la vacuna AZD1222 contra COVID-19 a Costa Rica
-
Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
-
Tagrisso is the only 1st-line treatment for EGFR-mutated non-small cell lung cancer to deliver a median overall survival of more than three years
Contact Us
If you have any questions you can contact us by email:
Viviana Agüero
Government Affairs & Comms Associate
+44 203 749 5916